1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

MLA

Laura Pontiggia, et al. “1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia.” Open Forum Infectious Diseases, vol. 5, no. Suppl 1, Nov. 2018, p. S318. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d51a900e206665055c92c27f7f08e500&authtype=sso&custid=ns315887.

APA

Laura Pontiggia, Matthew Fox, Klarida Zeqollari, Jessica L. Adams, Dana Byrne, Grant Lee, Madeline King, & Lucia Rose. (2018). 1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases, 5(Suppl 1), S318.

Chicago

Laura Pontiggia, Matthew Fox, Klarida Zeqollari, Jessica L. Adams, Dana Byrne, Grant Lee, Madeline King, and Lucia Rose. 2018. “1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia.” Open Forum Infectious Diseases 5 (Suppl 1): S318. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d51a900e206665055c92c27f7f08e500&authtype=sso&custid=ns315887.